Yuval Harris (PhD student)

Yuval Harris got her B.Sc. in Biomedical Engineering from the Technion and currently pursuing a Ph.D. in Biomedical Engineering as a Clore Scholar. Her research focuses on combinatorial nanomedicine for treating KRAS-driven cancers, including the development of indolium-stabilized nanoparticles and in vivo evaluation of multi-drug formulations. She integrates both experimental and translational approaches to advance personalized drug delivery strategies.

​

Publications:

Y. Harris, H. Sason, D. Niezni, and Y. Shamay, “Automated discovery of nanomaterials via drug aggregation induced emission,” Biomaterials, vol. 289, p. 121800, Oct. 2022, doi: 10.1016/j.biomaterials.2022.121800. Link

​​​

D. Niezni, Y. Harris, H. Sason, M. Avrashami, and Y. Shamay, “Polydopamine Copolymers for Stable Drug Nanoprecipitation,” Int. J. Mol. Sci., vol. 23, no. 20, p. 12420, Oct. 2022, doi: 10.3390/ijms232012420. Link

​

D. Niezni, H. Taub-Tabib, Y. Harris, H. Sason, Y. Amrusi, D. Meron-Azagury, M. Avrashami, S. Launer-Wachs, J. Borchardt, M. Kusold, A. Tiktinsky, T. Hope, Y. Goldberg, and Y. Shamay, “Extending the boundaries of cancer therapeutic complexity with literature text mining,” Artificial Intelligence in Medicine, vol. 145, p. 102681, 2023, doi: 10.1016/j.artmed.2023.102681. Link

​

D. M. Azagury, B. F. Gluck, Y. Harris, Y. Avrutin, D. Niezni, H. Sason, and Y. Shamay, “Prediction of cancer nanomedicines self-assembled from meta-synergistic drug pairs,” Journal of Controlled Release, vol. 360, pp. 418–432, Aug. 2023, doi: 10.1016/j.jconrel.2023.06.040. Link